Selected technologies for measuring acquired genetic damage in humans.

Area of Science:

• Genetics
• Molecular Biology
• Genomics

Background:

• Technical advances have significantly improved the detection and quantification of genetic variants.
• The polymerase chain reaction (PCR) is a cornerstone of genetic testing and mutation detection.
• Genetic variations encompass inherited germline mutations and polymorphisms, as well as acquired somatic mutations.

Purpose of the Study:

• To review current methods for assessing acquired somatic mutations in the genome.
• To examine the application of these methods in molecular epidemiology and disease analysis.
• To highlight the impact of emerging technologies on the discovery of disease-associated mutations.

Main Methods:

• Review of current technologies for assessing acquired somatic mutations.
• Focus on next-generation sequencing (NGS) for comparative whole-genome sequencing.
• Discussion of emerging microfluidic technologies for single-cell genetic analysis.

Main Results:

• NGS systems offer high-throughput and high-sensitivity for discovering disease-associated acquired mutations.
• Microfluidic technologies enable single-cell genetic analysis, crucial for investigating tumor heterogeneity.
• These advancements are transforming the understanding of acquired genetic mutations and their causative mechanisms.

Conclusions:

• Advanced sequencing and microfluidic technologies are revolutionizing the study of acquired somatic mutations.
• These tools are essential for molecular epidemiology, disease detection, and understanding mutagenesis.
• Further research using these technologies will expand knowledge of genetic mutations and disease mechanisms.